Community-Associated Methicillin-Resistant Staphylococcus aureus : Epidemiology and Clinical Consequences of an Emerging Epidemic
Open accessThe DOI matches its Crossref record; 1,051 of the 1,053 references it cites were found in a registry or an index.
Abstract
SUMMARY: Staphylococcus aureus is an important cause of skin and soft-tissue infections (SSTIs), endovascular infections, pneumonia, septic arthritis, endocarditis, osteomyelitis, foreign-body infections, and sepsis. Methicillin-resistant S. aureus (MRSA) isolates were once confined largely to hospitals, other health care environments, and patients frequenting these facilities. Since the mid-1990s, however, there has been an explosion in the number of MRSA infections reported in populations lacking risk factors for exposure to the health care system. This increase in the incidence of MRSA infection has been associated with the recognition of new MRSA clones known as community-associated MRSA (CA-MRSA). CA-MRSA strains differ from the older, health care-associated MRSA strains; they infect a different group of patients, they cause different clinical syndromes, they differ in antimicrobial susceptibility patterns, they spread rapidly among healthy people in the community, and they frequently cause infections in health care environments as well. This review details what is known about the epidemiology of CA-MRSA strains and the clinical spectrum of infectious syndromes associated with them that ranges from a commensal state to severe, overwhelming infection. It also addresses the therapy of these infections and strategies for their prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“upon breaching this initial site of colonization, S. aureus has the capacity to infect nearly every tissue in the human body.”
From A battle for iron: host sequestration and Staphylococcus aureus acquisition (2012) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“S. aureus can cause a spectrum of ailments ranging from superficial wound infections to more severe diseases such as septicemia, toxic shock syndrome and endocarditis [2].”
From A battle for iron: host sequestration and Staphylococcus aureus acquisition (2012) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“in the last two decades there has been a dramatic increase in community acquired MRSA infections within populations that have not had identifiable exposure to health care institutions [2].”
From A battle for iron: host sequestration and Staphylococcus aureus acquisition (2012) · cites this paper as [2]
In the citing paper
“CA-MRSA is generally less resistant overall, primarily exhibiting resistance to β-lactam antibiotics while remaining susceptible to many non-β-lactam agents such as clindamycin and trimethoprim-sulfamethoxazole [276].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [276]
In the citing paper
“Additionally, many CA-MRSA strains produce the PVL toxin, which contributes to severe necrotizing infections, including skin and SSTIs and necrotizing pneumonia [276].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [276]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204 · cited 27×
“Individuals TABLE 10—Continued Animals Yr ofstudy Location(s) Major finding(s) Isolate characteristic(s) b Reference(s) 2002–2003 Pennsylvania 8 dogs with MRSA infections 5 different PFGE types, all PVL 869 Not stated United Kingdom Pet therapy dog with MRSA colonization in pooled culture of nose, scalp, and interdigi…”
BackgroundInfluentialStaphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Kluytmans, J., van Belkum, A., & Verbrugh, H. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.505 · Cited by 2,595
Research works printed but not linked: 18
- Anonymous. 1994. Tentative final monograph for health care antiseptic products: proposed rule. Fed. Regist.59:31402-31452.
- Prisoners in 1999 bulletin. 2000
- Centers for Disease Control and Prevention. 2008. Progress in introduction of pneumococcal conjugate vaccine—worldwide, 2000-2008. MMWR Morb. Mortal. Wkly. Rep.57:1148-1151.
- Cribier, B., G. Prévost, P. Couppie, V. Finck-Barbançon, E. Grosshans, and Y. Piémont. 1992. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology185:175-180.
- 10.1111/j.1553-2712.2007.tb00368.x · doi:10.1111/j.1553-2712.2007.tb00368.x
- 10.3201/eid1405.070153 · doi:10.3201/eid1405.070153
- Health Protection Agency. 2005. Community MRSA in England and Wales: definition through strain characterisation. Commun. Dis. Rep. Wkly.15:11. http://www.hpa.org.uk/cdr/archives/2005/cdr1105.pdf .
- Health Protection Agency. 2006. Hospital-associated transmission of Panton-Valentine leukocidin (PVL) positive community-associated MRSA in the West Midlands. Commun. Dis. Rep. Wkly.16:50. http://www.hpa.org.uk/cdr/archives/2006/cdr5006.pdf .
- 10.1111/j.1444-0903.2001.00029.x · doi:10.1111/j.1444-0903.2001.00029.x · Paper page
- Huijsdens, X. W., M. Janssen, N. H. M. Renders, A. Leenders, P. van Wijk, M. G. van Santen-Verheuvel, J. K. van-Driel, and G. Morroy. 2008. Methicillin-resistant Staphylococcus aureus in a beauty salon, the Netherlands. Emerg. Infect. Dis.14:1197-1199.
- 10.1016/j/jemermed.2009.05.015 · doi:10.1016/j/jemermed.2009.05.015
- 10.2307/30140995 · doi:10.2307/30140995 · Paper page
- 10.1086/502213 · doi:10.1086/502213 · Paper page
- Seifried, S. E., A. D. Tice, and M. Eischen. 2007. Diversity of community-associated strains of methicillin-resistant Staphylococcus aureus in Hawaii. J. Infect. Dis.195:305.
- 10.2307/30105108 · doi:10.2307/30105108
- 10.3201/eid1203.050625 · doi:10.3201/eid1203.050625
- Van de Velde, H. 1894. Étude sur la mécanisme de la virulence du staphylocoque pyogène. Cellule10:402-460.
- 10.1111/j.1469-0691.2009.02836.x.x · doi:10.1111/j.1469-0691.2009.02836.x.x
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Mobile Genetic Elements Associated with Antimicrobial Resistance
Partridge, S. R., Kwong, S. M., Firth, N., & Jensen, S. O. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00088-17 · Cited by 2,751
Rizzo, L., Manaia, C., Merlin, C., Schwartz, T., Dagot, C., Ploy, M. C., Michael, I., & Fatta-Kassinos, D. (2013) · Science of The Total Environment · doi:10.1016/j.scitotenv.2013.01.032 · Cited by 2,493
“Indeed, the emergence of antibiotic resistance may result from either or both, the progressive enrichment of resistant bacteria, and the transfer of resistance genes between microbial members of a given community (Courvalin, 2008; David and Daum, 2010; Stokes and Gillings, 2011).”
BackgroundMethicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0147-4 · Cited by 2,051
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
“As a consequence, people now prefer a strain-based definition of CA-MRSA, as it has a unique genetic profile, antibiotic resistance pattern, presentation, epidemiology, and treatment (442, 577, 579, 580).”
BackgroundInfluential
Metadata
- Authors
- David, M. Z., & Daum, R. S.
- Affiliations
- University of Chicago (US)
- ORCID
- David, Michael Z.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2010-07
- Volume
- 23
- Issue
- 3
- Pages
- 616-687
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC2901661
- OpenAlex
- W2125066910
- Cited by
- 1,972
- References
- 1,053
- Citations by year
- 2026: 90 · 2025: 97 · 2024: 110 · 2023: 99 · 2022: 84 · 2021: 123 · 2020: 110 · 2019: 138 · 2018: 109 · 2017: 138 · 2016: 173 · 2015: 159 · 2014: 188 · 2013: 143 · 2012: 128
- FWCI
- 12.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- community-acquired MRSA, methicillin-resistant Staphylococcus aureus, MRSA epidemiology, skin and soft tissue infections, antimicrobial susceptibility, MRSA clones, healthcare-associated MRSA, MRSA infection prevention, sepsis, endocarditis, osteomyelitis
- MeSH terms
- Anti-Bacterial Agents, Bacterial Proteins, Disease Outbreaks, Genotype, Humans, Staphylococcal Infections, Bacterial Typing Techniques, Community-Acquired Infections, Molecular Epidemiology, Drug Resistance, Multiple, Bacterial, Virulence Factors, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Community-Associated Methicillin-Resistant Staphylococcus aureus : Epidemiology and Clinical Consequences of an Emerging Epidemic. https://app.cochat.ai/papers/10.1128/cmr.00081-09
- The paper
- David, M. Z., & Daum, R. S. (2010). Community-Associated Methicillin-Resistant Staphylococcus aureus : Epidemiology and Clinical Consequences of an Emerging Epidemic. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00081-09
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.